DOCSLIB.ORG

PROGRAM BOOK Welcome! the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) Would Like to Welcome You to Our 46Th Annual Meeting

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PROGRAM BOOK Welcome! the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) Would Like to Welcome You to Our 46Th Annual Meeting WWW.AAPOS.ORG DISCOVER NEW POINTS OF VIEW PROGRAM BOOK Welcome! The American Association for Pediatric Ophthalmology and Strabismus (AAPOS) would like to welcome you to our 46th Annual Meeting. We have an exciting program scheduled and are pleased that you have decided to join us! About the American Association for Pediatric Ophthalmology and Strabismus AAPOS was formed in 1974 and has over 1900 members. Membership includes the vast majority of practicing fellowship-trained, board-certified pediatric ophthalmologists and adult strabismus specialists in the United States and Canada, as well as over 500 international members. Each year, AAPOS conducts an annual scientific meeting at a location in North America. Annual Meeting attendance in recent years has averaged over 1000 professionals, including approximately 800 physicians. AAPOS 2021 virtual meeting APRIL 911 DISCOVER NEW POINTS OF VIEW Contents Meeting Information ........................................................................................................... 2 AAPOS Leadership ............................................................................................................. 2 Past Presidents.................................................................................................................... 3 AAPOS Educational Mission ..............................................................................................4 Continuing Medical Education .......................................................................................... 5 Financial Disclosures ..........................................................................................................6 Awards and Lectures .......................................................................................................... 7 Program Schedule .............................................................................................................10 Posters .................................................................................................................................18 Future AAPOS Meetings ........................................................................inside back cover AAPOS Board of Directors Program Committee President Chair Katherine A. Lee, MD, PhD David K. Wallace, MD, MPH Meeting View Abstracts The meeting program with Executive Vice President Lisa Bohra, MD Information abstracts can be viewed on Christie L. Morse, MD the AAPOS website, under the Brenda L. Bohnsack, MD, PhD Vice President All times listed in the program meetings tab. Oscar A. Cruz, MD M. Edward Wilson, Jr, MD book are in Eastern Daylight Time. Vice President Elect Leah Reznick, MD Robert S. Gold, MD In the virtual meeting platform, Kimberly Merrill, CO the schedule will automatically Past President adjust to your time zone. Rahul Bhola, MD Jane C. Edmond, MD Posters Visit the Exhibitors! Secretary/Treasurer Interactive Poster Session – Eric A. Lichtenstein, MD Staff Friday, April 9 Author Presentation and Q/A. Associate Director 12:30 PM – 1:30 PM (EDT) Authors will be present in Secretary for Program Jennifer Hull Saturday, April 10 individual chat rooms. David K. Wallace, MD, MPH 11:30 AM – 12:30 PM (EDT) Scientific Program Coordinator Visit individual posters and Director at Large Maria A. Schweers, CO Sunday, April 11 click “join” during office hours Mary A. O'Hara, MD 11:30 AM – 12:30 PM (EDT) to meet with an author or type Client Services Coordinator a question on the discussion Director at Large Christina Scott Faruk H. Orge, MD Claim Your CME Credits tab for authors to answer after Communications Manager Online! office hours. Director at Large Gina Minato Visit the AAPOS website by Friday, April 9 Yasmin S. Bradfield, MD July 15, 2021 to claim your CME 1st Set of Posters (A1 – A75) Meetings Manager credits: www.aapos.org. 12:30 PM – 1:30 PM (EDT) CEF of AAPOS Advisory Board Michael Paulos, CMP Saturday, April 10 Chairman Derek T. Sprunger, MD 2nd Set of Posters (B1 – B75) 11:30 AM – 12:30 PM (EDT) Councilor to AAO Sunday, April 11 Scott A. Larson, MD 3rd Set of Posters (C1 – C78) 11:30 AM – 12:30 PM (EDT) Workshop Handouts Handouts for workshops can be Poster Viewing without downloaded from the AAPOS authors present website, under the meetings Friday, April 9 tab. 8:00 AM – 10:00 AM (EDT) Saturday, April 10 8:00 AM – 10:00 AM (EDT) Sunday, April 11 8:00 AM – 10:00 AM (EDT) 2 AAPOS 2021 VIRTUAL MEETING PROGRAM BOOK Thomas D. France, MD John W. Simon, MD C. Gail Summers, MD AAPOS Past Presidents Maui, HI Palm Springs, CA Orlando, FL Marshall M. Parks, MD 1985–1986 1997–1998 2009–2010 Lake Tahoe, NV 1974–1975 Gunter K. von Noorden, MD Marilyn T. Miller, MD David A. Plager, MD Scottsdale, AZ Toronto, Canada San Diego, CA Robert D. Reinecke, MD 1986–1987 1998–1999 2010–2011 Bermuda 1975–1976 Arthur L. Rosenbaum, MD Maynard B. Wheeler, MD Steven E. Rubin, MD Boston, MA San Diego, CA San Antonio, TX Jack C. Crawford, MD 1987–1988 1999–2000 2011–2012 San Francisco, CA 1976–1977 William E. Scott, MD Albert W. Biglan, MD K. David Epley, MD Kiawah, SC Orlando, FL Boston, MA Robison D. Harley, MD 1988–1989 2000–2001 2012–2013 Williamsburg, VA 1977–1978 Eugene M. Helveston, MD Jane D. Kivlin, MD Sharon F. Freedman, MD Lake George, NY Seattle, WA Palm Springs, CA David S. Friendly, MD 1989–1990 2001–2002 2013–2014 Toronto, Canada 1978–1980 Henry S. Metz, MD Joseph H. Calhoun, MD Sherwin J. Isenberg, MD Montreal, Canada Waikoloa, HI New Orleans, LA Phillip Knapp, MD 1990–1991 2002–2003 2014–2015 San Diego, CA 1979–1980 John T. Flynn, MD George S. Ellis, Jr, MD M. Edward Wilson, Jr, MD Maui, HI Washington, DC Vancouver, Canada Webb Chamberlain, MD 1991–1992 2003–2004 2015–2016 Orlando, FL 1980–1981 Forrest D. Ellis, MD Susan H. Day, MD Robert E. Wiggins, JR, MD, MHA Palm Springs, CA Orlando, FL Nashville, TN Arthur Jampolsky, MD 1992–1993 2004–2005 2016–2017 Monterey, CA 1981–1982 David L. Guyton, MD Michael X. Repka, MD, MBA Derek T. Sprunger, MD Vancouver, BC Keystone, CO Washington, DC Alfred G. Smith, MD 1993–1994 2005–2006 2017–2018 Vancouver, BC 1982–1983 Malcolm L. Mazow, MD Christie L. Morse, MD R. Michael Siatkowski, MD Orlando, FL Seattle, WA San Diego, CA John A. Pratt–Johnson, MD 1994–1995 2006–2007 2018–2019 Vail, CO 1983–1984 John D. Baker, MD Edward G. Buckley, MD Jane C. Edmond, MD Snowbird, UT Washington, DC Austin, TX Eugene R. Folk, MD 1995–1996 2007–2008 Meeting Canceled Due to Puerto Rico COVID-19 1984–1985 Earl A. Palmer, MD Bradley C. Black, MD 2019–2020 Charleston, SC San Francisco, CA 1996–1997 2008–2009 AAPOS 2021 VIRTUAL MEETING PROGRAM BOOK 3 AAPOS Educational Mission Statement The purpose of the American Association for Pediatric Ophthalmology Additionally, AAPOS’ educational program provides content for topics such and Strabismus’ (AAPOS) educational activities is to present pediatric as effective management of a pediatric ophthalmology practice, medical ophthalmologists and strabismologists with the highest quality lifelong ethics, risk management, and other areas deemed relevant by the needs learning opportunities that promote improvement and change in physi- of the membership. cian practices, performance, or competence through joint sponsorship with Medical Education Resources (MER), thus enabling such physicians to Types of educational activities provided at the annual AAPOS meeting maintain or improve the competence and professional performance needed include: to provide the best possible eye care for their patients. · Didactic lectures Due to the nature of the subspecialty, the largest component of AAPOS’ · Original research in the form of free papers and posters educational program focuses on strabismus, amblyopia, visual development and binocular function. However, the content also emphasizes the other · In-depth focused workshops and symposia on specific topics Practice Emphasis Areas (PEAs) that have been defined by the American Board of Ophthalmology (ABO) for their Maintenance of Certification (MOC) · Small-group discussion opportunities with speakers and researchers process with emphasis on these disease processes in children, and adults with strabismus and eye movement disorders. These include: All meeting content is reviewed by the AAPOS Program Committee and Secretary for Program with respect to education quality and utility. Members · Cataract and Anterior Segment are routinely queried regarding their assessment of quality and content, as well as needs for future meetings, and comments are reviewed by the · Cornea and External Disease Program Committee and Board of Directors, with necessary changes incorporated into future programs. · Glaucoma The expected result of AAPOS’ educational activities is a broad array of · Neuro-ophthalmology and Orbit ophthalmic knowledge that contributes to the lifelong learning of members · Oculoplastics and Orbit and advances physician performance or competence. Ongoing assessment of the impact of AAPOS’ educational program is important in determining · Refractive Management and Intervention modifications to existing activities and the development of new activities. Specific expected results include increased knowledge across the ophthalmic · Retina and Vitreous community, activities designed to increase competence and performance with evidence-based standards, current practices, and methods of diagnosis, · Uveitis therapies, and disease prevention. 4 AAPOS 2021 VIRTUAL MEETING PROGRAM BOOK Continuing Medical Education Accreditation Statement 6. Describe new treatment strategies to decrease the
Load more

Recommended publications
  • A Patient & Parent Guide to Strabismus Surgery
    A Patient & Parent Guide to Strabismus Surgery By George R. Beauchamp, M.D. Paul R. Mitchell, M.D. Table of Contents: Part I: Background Information 1. Basic Anatomy and Functions of the Extra-ocular Muscles 2. What is Strabismus? 3. What Causes Strabismus? 4. What are the Signs and Symptoms of Strabismus? 5. Why is Strabismus Surgery Performed? Part II: Making a Decision 6. What are the Options in Strabismus Treatment? 7. The Preoperative Consultation 8. Choosing Your Surgeon 9. Risks, Benefits, Limitations and Alternatives to Surgery 10. How is Strabismus Surgery Performed? 11. Timing of Surgery Part III: What to Expect Around the Time of Surgery 12. Before Surgery 13. During Surgery 14. After Surgery 15. What are the Potential Complications? 16. Myths About Strabismus Surgery Part IV: Additional Matters to Consider 17. About Children and Strabismus Surgery 18. About Adults and Strabismus Surgery 19. Why if May be Important to a Person to Have Strabismus Surgery (and How Much) Part V: A Parent’s Perspective on Strabismus Surgery 20. My Son’s Diagnosis and Treatment 21. Growing Up with Strabismus 22. Increasing Signs that Surgery Was Needed 23. Making the Decision to Proceed with Surgery 24. Explaining Eye Surgery to My Son 25. After Surgery Appendix Part I: Background Information Chapter 1: Basic Anatomy and Actions of the Extra-ocular Muscles The muscles that move the eye are called the extra-ocular muscles. There are six of them on each eye. They work together in pairs—complementary (or yoke) muscles pulling the eyes in the same direction(s), and opposites (or antagonists) pulling the eyes in opposite directions.
    [Show full text]
  • Pediatric Ophthalmology/Strabismus 2017-2019
    Academy MOC Essentials® Practicing Ophthalmologists Curriculum 2017–2019 Pediatric Ophthalmology/Strabismus *** Pediatric Ophthalmology/Strabismus 2 © AAO 2017-2019 Practicing Ophthalmologists Curriculum Disclaimer and Limitation of Liability As a service to its members and American Board of Ophthalmology (ABO) diplomates, the American Academy of Ophthalmology has developed the Practicing Ophthalmologists Curriculum (POC) as a tool for members to prepare for the Maintenance of Certification (MOC) -related examinations. The Academy provides this material for educational purposes only. The POC should not be deemed inclusive of all proper methods of care or exclusive of other methods of care reasonably directed at obtaining the best results. The physician must make the ultimate judgment about the propriety of the care of a particular patient in light of all the circumstances presented by that patient. The Academy specifically disclaims any and all liability for injury or other damages of any kind, from negligence or otherwise, for any and all claims that may arise out of the use of any information contained herein. References to certain drugs, instruments, and other products in the POC are made for illustrative purposes only and are not intended to constitute an endorsement of such. Such material may include information on applications that are not considered community standard, that reflect indications not included in approved FDA labeling, or that are approved for use only in restricted research settings. The FDA has stated that it is the responsibility of the physician to determine the FDA status of each drug or device he or she wishes to use, and to use them with appropriate patient consent in compliance with applicable law.
    [Show full text]
  • Pediatric Cataracts: a Retrospective Study of 12 Years (2004
    Pediatric Cataracts: A Retrospective Study of 12 Years (2004 - 2016) Cataratas em Idade Pediátrica: Estudo Retrospetivo de 12 ARTIGO ORIGINAL Anos (2004 - 2016) Jorge MOREIRA1, Isabel RIBEIRO1, Ágata MOTA1, Rita GONÇALVES1, Pedro COELHO1, Tiago MAIO1, Paula TENEDÓRIO1 Acta Med Port 2017 Mar;30(3):169-174 ▪ https://doi.org/10.20344/amp.8223 ABSTRACT Introduction: Cataracts are a major cause of preventable childhood blindness. Visual prognosis of these patients depends on a prompt therapeutic approach. Understanding pediatric cataracts epidemiology is of great importance for the implementation of programs of primary prevention and early diagnosis. Material and Methods: We reviewed the clinical cases of pediatric cataracts diagnosed in the last 12 years at Hospital Pedro Hispano, in Porto. Results: We identified 42 cases of pediatric cataracts with an equal gender distribution. The mean age at diagnosis was 6 years and 64.3% of patients had bilateral disease. Decreased visual acuity was the commonest presenting sign (36.8%) followed by leucocoria (26.3%). The etiology was unknown in 59.5% of cases and there was a slight predominance of nuclear type cataract (32.5%). Cataract was associated with systemic diseases in 23.8% of cases and with ocular abnormalities in 33.3% of cases. 47.6% of patients were treated surgically. Postoperative complications occurred in 35% of cases and posterior capsular opacification was the most common (25%). Discussion: The report of 42 cases is probably the result of the low prevalence of cataracts in this age. Although the limitations of our study include small sample size, the profile of children with cataracts in our hospital has characteristics relatively similar to those described in the literature.
    [Show full text]
  • Pediatric Glaucoma
    CLINICAL STRATEGIES Pediatric Glaucoma Advice on diagnosing and managing a rare but potentially devastating group of diseases. BY SHARON F. FREEDMAN, MD hildhood glaucomas are infrequently encoun- try between the corneas of the infant’s eyes. Rapid corneal tered by many eye care providers and can there- stretching may lead to breaks in Descemet’s membrane fore be challenging to diagnose. Because this het- called Haab’s striae, which will leave permanent scars Cerogeneous group of diseases can cause a rapid (Figure 1). Oftentimes, the affected infant is photophobic loss of vision or even blindness, however, the timely recog- (Figure 2) and may have tearing that the clinician must dis- nition and optimal treatment of pediatric glaucoma is criti- tinguish from nasolacrimal duct obstruction.1,2 cal. Fortunately, ophthalmologists often have at their dis- Newborns with healthy eyes have a corneal diameter of posal the tools needed to diagnose and begin to manage approximately 9.5 to 10.0 mm. A corneal diameter of these children. Usually, the ideal care of patients with pedi- greater than 12.0 mm in any infant younger than 1 year is atric glaucoma involves the efforts of more than one oph- therefore suspicious for glaucoma.3 The IOP usually thalmologist, unless a pediatric glaucoma specialist is locat- ranges from 10 to 15 mm Hg in newborns, whereas the ed near the child’s home. IOP in children of school age resembles that of adults. Most children with glaucoma will have an IOP that is BACKGROUND higher than 22 mm Hg. The most common form of pediatric glaucoma, primary Although infants and children under the age of 2 often congenital glaucoma, occurs in approximately one in present with signs and symptoms related to rapid ocular 10,000 individuals.1 As with adult forms of the disease, expansion under high IOP, older children without an acute- pediatric glaucoma may be primary or secondary.
    [Show full text]
  • AAPOS – SPOSI Joint Meeting, Jaipur, India, Preliminary Program – Subject to Changes
    AAPOS – SPOSI Joint Meeting, Jaipur, India, Preliminary Program – Subject to changes Friday, December 2, 2016 9:00 AM – 9:05 AM Opening Remarks & Welcome Room A and Room B Sean P. Donahue, MD, PhD 9:05 AM – 10:35 AM Childhood Visual Impairment: Detection, Assessment, and Rehabilitation Room A and Room B 9:05 AM – 9:41 AM Blindness and Prevention of Visual Impairment in Children 9:05 AM – 9:06 AM Introduction Sherwin J. Isenberg, MD 9:06 AM – 9:24 AM Childhood Blindness World Wide: Current Status Clare Gilbert, MB ChB, FRCOphth, MD, MSc 9:24 AM – 9:32 AM The NGO’s Role in Treating and Preventing Blindness Marilyn T. Miller, MD Victoria Sheffield, President and CEO, International Eye Foundation 9:32 AM – 9:38 AM Epidemiology of Eye Disease in Children Birth to 3 in a Tertiary Eye Center in India P. Vijayalakshmi, MS, DO 9:38 AM – 9:41 AM Question and Answer Session 9:41 AM – 10:06 AM Early Detection and Assessment of Visual Impairment in Children 9:41 AM – 9:42 AM Introduction Linda Lawrence, MD 9:42 AM – 9:57 AM How the Pediatric Ophthalmologist Diagnoses CVI and Why? Gordon Dutton, MD, FRCS Ed (hon), FRCOphth 9:57 AM – 10:03 AM Early Detection Should Lead to Early Intervention; Rural Initiatives Kalpana Narendran, MBBS, DO, DNB 10:03 AM – 10:06 AM Question and Answer Session 10:06 AM – 10:35 AM Rehabilitation for Children with Visual Impairment 10:06 AM – 10:07 AM Introduction Albert Biglan, MD 10:07 AM – 10:17 AM Interventions from the Ophthalmologist’s Perspective Lea Hyvärinen, MD, PhD 10:17 AM – 10:25 AM Interventions from the Rehabilitation
    [Show full text]
  • Abnormal Red Reflex: Etiologies in a Pediatric Ophthalmology Population
    CPJXXX10.1177/0009922820916892Clinical PediatricsLin et al 916892research-article2020 Article Clinical Pediatrics 2020, Vol. 59(8) 760 –765 Abnormal Red Reflex: Etiologies in a © The Author(s) 2020 Article reuse guidelines: sagepub.com/journals-permissions Pediatric Ophthalmology Population DOI:https://doi.org/10.1177/0009922820916892 10.1177/0009922820916892 journals.sagepub.com/home/cpj Sophie Y. Lin, BA1 , Kimberly G. Yen, MD1,2, Huirong Zhu, PhD2, Alexis Moisiuc, BS2, and Madhuri Chilakapati, MD1,2 Abstract Children who present with an abnormal red reflex (ARR) are often referred to ophthalmology due to concern for retinoblastoma. However, an ARR can indicate a wide variety of pathologies, all of which have the potential to develop amblyopia and irreversible vision loss. In this retrospective cohort study, we demonstrate that children who presented with an ARR had a mean age of 22.0 ± 32.5 months and were more frequently referred by their pediatricians (74.5%). The majority of these patients (61.8%) had a normal examination on further evaluation, followed by refractive error (20.4%). Amblyopia was diagnosed in 83.9% of patients with refractive error, with a mean age of 50.3 ± 49.2 months. Because many ARR-associated pathologies require time-sensitive treatment to prevent vision loss, proper screening is critical for diagnosis. Pediatricians play a key role in screening, so education on more common ARR pathologies can better facilitate referrals and improve outcomes. Keywords abnormal red reflex, leukocoria, screening Introduction to any ocular condition that limits visual stimulation to the eye so if amblyopia is not treated early, vision loss Eliciting the red reflex is a useful clinical test used by can be irreversible.
    [Show full text]
  • Update on Orthokeratology in Managing Progressive Myopia in Children: Efficacy, Mechanisms, and Concerns
    Review Article Update on Orthokeratology in Managing Progressive Myopia in Children: Efficacy, Mechanisms, and Concerns Xintong Li, MD; Ilana B. Friedman, MD; Norman B. Medow, MD; Cheng Zhang, MD ABSTRACT INTRODUCTION Myopia is an important public health issue, and high my- Myopia, commonly known as near-sightedness, opia may lead to severe complications if left untreated. is a spherical refractive error that causes light to fo- Orthokeratology lenses, worn overnight to reshape the cus in front of the retina, resulting in blurry distance cornea, are one of many recent modalities used to slow vision while preserving clearer near vision. It is due down the progression of myopia in children. This treat- to axial lengthening of the globe or increased refrac- ment has been proven successful, as evidenced by de- tive power of the eye. Epidemiologic studies of this creased spherical refractive error and axial length relative condition are complicated by age, ethnicity, and the to the control at interval follow-up ranging from 6 months degree of spherical refractive error needed to label an to 5 years. In this systematic review, the authors collected eye as myopic, and its prevalence ranges from 33% published controlled studies that analyzed the efficacy in whites to approximately 90% in East Asians. In of orthokeratology lens wear and calculated longitudi- addition to increasing functional impairment of nal relative changes in axial length, revealing a weighted the patient, myopia increases the risk of subretinal average of -45.1% change in
    [Show full text]
  • Retinopathy of Prematurity
    INVITED COMMENTARY Retinopathy of Prematurity Alice L. Bashinsky Retinopathy of prematurity (ROP) is a vasoproliferative 90% experience spontaneous regression, and between retinal disorder unique to premature infants. As premature 1,100 and 1,500 develop disease severe enough to require births increase in many areas of the world, ROP has become medical treatment [7]. The Cryotherapy for Retinopathy of a leading cause of childhood blindness. A better understand- Prematurity (CRYO-ROP) Cooperative Group determined ing of the pathogenesis of ROP, adherence to strict screening that ROP occurred in 66% of infants with a birth weight of guidelines, and evolution of treatment options have reduced 1,250 g or less and in 82% of infants with a birth weight of the number of sight-threatening complications from ROP. less than 1,000 g [3]. Despite appropriate medical interven- tions, 400 to 600 infants each year in the United States become legally blind from ROP [7]. etinopathy of prematurity (ROP) is a disorder of reti- Gestational age and birth weight, the two greatest risk Rnal blood vessel development in low birth weight pre- factors for ROP, are inversely correlated with the develop- term infants and is the second leading cause of childhood ment of ROP. Specifically, smaller babies and those born at blindness in the United States behind cortical visual impair- an earlier gestational age are at higher risk. Between 1986 ment [1]. ROP is a complex disease process initiated in part and 2013, the birth weight and gestational age of infants by a lack of complete retinal vascularization in premature enrolled in ROP studies in the United States decreased, infants.
    [Show full text]
  • Procedures for the Evaluation of the Visual System by Pediatricians Sean P
    CLINICAL REPORT Guidance for the Clinician in Rendering Pediatric Care Procedures for the Evaluation of the Visual System by Pediatricians Sean P. Donahue, MD, PhD, FAAP, Cynthia N Baker, MD, FAAP, COMMITTEE ON PRACTICE AND AMBULATORY MEDICINE, SECTION ON OPHTHALMOLOGY, AMERICAN ASSOCIATION OF CERTIFIED ORTHOPTISTS, AMERICAN ASSOCIATION FOR PEDIATRIC OPHTHALMOLOGY AND STRABISMUS, AMERICAN ACADEMY OF OPHTHALMOLOGY Vision screening is crucial for the detection of visual and systemic disorders. It abstract should begin in the newborn nursery and continue throughout childhood. This clinical report provides details regarding methods for pediatricians to use for screening. This clinical report supplements the combined policy statement from the American Academy of Pediatrics (AAP), American Association for Pediatric Ophthalmology and Strabismus, American Academy of Ophthalmology, and American Association of Certified Orthoptists titled “Visual System Assessment in Infants, Children, and Young Adults by Pediatricians.”1 The clinical report and accompanying policy statement supplant the 2012 policy statement “Instrument-Based Pediatric Vision Screening,”2 the 2003 policy statement “Eye Examination in Infants, Children, and Young Adults by Pediatricians,”3 and the 2008 AAP policy statement “Red Reflex Examination in Neonates Infants and Children.”4 The policy statement This document is copyrighted and is property of the American articulates the screening criteria and screening methods, and the clinical Academy of Pediatrics and its Board of Directors. All authors have filed report explains the various evaluation procedures that are available for conflict of interest statements with the American Academy of Pediatrics. Any conflicts have been resolved through a process use by the pediatrician or primary care physician. approved by the Board of Directors.
    [Show full text]
  • Management of Retinopathy of Prematurity in a Neonatal Unit
    [Downloaded free from http://www.jcnonweb.com on Thursday, October 31, 2019, IP: 181.64.200.181] Review Article Management of Retinopathy of Prematurity in a Neonatal Unit: Current Approach Hussain Parappil1,2, Anant Pai3, Nazla Abdelmonem Mahmoud1, Mohammad Ayman AlKhateeb1,2, Hilal Al Rifai1,2, Maha Mohammed El Shafei3 1 Department of Neonatology, Retinopathy of prematurity (ROP) is a blinding morbidity affecting preterm Women’s Wellness and infants. It currently represents the leading preventable cause of childhood blindness Research Centre, Hamad Medical Corporation, worldwide. Most data indicate an increasing incidence of ROP disease in both 2Department of Pediatrics, industrialized countries and in the developing world. There are neither symptoms Abstract Weill Cornell Medical of ROP nor can a specific visual behavior in a preterm infant herald a concern for College, 3Department of ROP. Hence, an effective screening is essential for prompt diagnosis of ROP. The Ophthalmology, Hamad available evidence suggests that the majority of premature infants who go blind Medical Corporation, Doha, from ROP do so due to screening failure. Timely screening of premature infants at Qatar risk is as important as early treatment in the management of ROP. The screening protocol at each neonatal intensive care unit (NICU) should be evidence‑based, should be based on preferences of neonatologists, ophthalmologists, and NICU nurses. All at‑risk infants should be identified and receive adequate dilated retinal examinations at appropriate times. Appropriate screening and follow‑up guidelines and timely treatment protocols need to be implemented in every NICU by pediatricians and ophthalmologists to reduce the ROP‑related blindness in the community.
    [Show full text]
  • And Strabismus Second Edition Springer Science+Business Media, LLC Pediatric Ophthalmology and Strabismus Second Edition
    The following tables can be used as a guideline in planning Strabismus surgery. These numbers have been derived from Marshall Parks, with modifications from the surgical experience of Kenneth W. Wright. The numbers are only a guide and should be modified as necessary. BINOCULAR SURGERY Esotropia MROU LR OU ET Recession ET Resection* 1S~ 3.0mm 1S~ 3.Smm 20~ 3.Smm 20~ 4.Smm 2S~ 4.0mm 2S~ S.Smm 30~ 4.Smm 30~ 6.0mm 3S~ S.Omm 3S~ 6.Smm 40~ S.Smm 40~ 7.0mm so~ 6.0mm so~ 8.0mm 60~ 6.Smm 70~ 7.0mm * When a lateral rectus resection is clone for residual esotropia after large medial rectus recession (6.00 mm or larger), these numbers should be lowered. Exotropia LR OU MROU XT Recession XT Resection 1S~ 4.0mm 1S~ 3.0mm 20~ S.Omm 20~ 4.0mm 2S~ 6.0mm 2S~ S.Omm 30~ 7.0mm 30~ S.Smm 3S~ 7.Smm 3S~ 6.0mm 40~ 8.0mm 40~ 6.Smm so~ 9.0mm MONOCULARSURGERY Esotropia Exotropia MR LR LR MR ET Recession Resection XT Resection Resection 1S~ 3.0 mm ............... 3.S mm 1S~ 4.0 mm ................ 3.0 mm 20~ 3.S mm ............... 4.0 mm 20~ S.O mm ................ 4.0 mm 2S~ 4.0 mm ............... S.O mm 2S~ 6.0 mm ................ 4.S mm 30~ 4.S mm ............... S.S mm 30~ 6.S mm ................ S.O mm 3S~ S.O mm ............... 6.0 mm 3S~ 7.0 mm ................ S.S mm 40~ S.S mm ..............
    [Show full text]
  • Pediatric Ophthalmology 2018 Winds of Change in the Windy City
    Pediatric Ophthalmology 2018 Winds of Change in the Windy City Program Directors Jonathan M Holmes MD and Scott A Larson MD In conjunction with the American Association for Pediatric Ophthalmology and Strabismus and the American Academy of Pediatrics McCormick Place Chicago, Illniois Saturday, Oct. 27, 2018 Presented by: The American Academy of Ophthalmology Pediatric Ophthalmology Subspecialty Day Advisory Committee Staff 2018 Planning Group Daniel S Durrie MD Melanie R Rafaty CMP DES, Director, Jonathan M Holmes MD Associate Secretary Scientific Meetings Program Director Julia A Haller MD Ann L’Estrange, Subspecialty Day Manager Scott A Larson MD Michael S Lee MD Carolyn Little, Presenter Coordinator Program Director Francis S Mah MD Debra Rosencrance CMP CAE, Vice President, Meetings & Exhibits Erick D Bothun MD R Michael Siatkowski MD Kuldev Singh MD MPH Patricia Heinicke Jr, Copy Editor Yasmin S Bradfield MD Mark Ong, Designer Michael F Chiang MD Maria M Aaron MD Gina Comaduran, Cover Designer Nils K Mungan MD Secretary for Annual Meeting Serena X Wang MD Tammy L Yanovitch MD ©2018 American Academy of Ophthalmology. All rights reserved. No portion may be reproduced without express written consent of the American Academy of Ophthalmology. ii Planning Group 2018 Subspecialty Day | Pediatric Ophthalmology 2018 Pediatric Ophthalmology Subspecialty Day Planning Group On behalf of the American Academy of Ophthalmology, the American Association for Pediatric Ophthalmology and Strabismus (AAPOS), and the American Academy of Pediatrics (AAP),
    [Show full text]